tradingkey.logo
tradingkey.logo
Search

Serina Therapeutics Inc

SER
Add to Watchlist
2.190USD
-0.120-5.19%
Close 09-23 16:00ET
32.85MMarket Cap
LossP/E TTM

SER Financials

See Serina Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
32.85M
Dividend TTM
0.00
P/E TTM
-1.15
EPS TTM
-1.96
Revenue
130.00K
Net Profit
-11.14M
ROE
-296.12%
ROA
-125.13%

Serina Therapeutics Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.55/-0.47
Revenue / Forecast
0.00/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
15.42%-0.55
-16.69%-0.58
-4.05%-0.31
-378.39%-0.44
-205.45%-0.64
85.41%-0.49
90.62%-0.30
103.18%0.16
124.71%0.61
-11.38%-3.38
-27.88%-3.20
---5.01
---2.47
---3.04
---2.51
---7.19
----
----
----
----
Revenue
-100.00%0.00
----
--0.00
-100.00%0.00
154.90%130.00K
-100.00%0.00
----
-79.10%14.00K
466.67%51.00K
-50.00%5.00K
600.00%56.00K
644.44%67.00K
-25.00%9.00K
100.00%10.00K
-70.37%8.00K
-62.50%9.00K
-67.57%12.00K
-91.07%5.00K
-82.91%27.00K
-65.22%24.00K
Net Profit
-38.52%-8.93M
-44.09%-6.93M
-21.75%-3.34M
-425.18%-4.58M
-223.90%-6.45M
49.00%-4.81M
20.72%-2.74M
126.11%1.41M
294.98%5.20M
-187.98%-9.44M
-27.86%-3.46M
-121.81%-5.40M
-1.95%-2.67M
-21.10%-3.28M
-25.25%-2.70M
-24.55%-2.44M
-5.82%-2.62M
-29.60%-2.71M
11.77%-2.16M
23.12%-1.96M
Net Margin
----
----
---14780.77%
----
-148.97%-4970.77%
----
----
222.82%9878.57%
134.10%10150.98%
-474.55%-188740.00%
82.11%-6175.00%
---8043.28%
---29766.67%
---32850.00%
---34512.50%
---29850.00%
----
----
----
----
Gross Margin
----
----
--100.00%
----
0.00%100.00%
----
----
97.06%100.00%
125.00%100.00%
11.11%100.00%
12.24%98.21%
--50.75%
--44.44%
--90.00%
--87.50%
--53.85%
----
----
----
----
Debt to assets ratio
--11.96%
--11.03%
--42.38%
-84.49%23.27%
----
----
-100.00%0.00%
725.63%150.05%
-61.27%104.13%
-59.81%96.38%
-93.48%36.48%
--18.17%
--268.88%
--239.83%
--559.21%
--779.18%
----
----
----
----
Revenue
-100.00%0.00
----
--0.00
-100.00%0.00
154.90%130.00K
-100.00%0.00
----
-79.10%14.00K
466.67%51.00K
-50.00%5.00K
600.00%56.00K
644.44%67.00K
-25.00%9.00K
100.00%10.00K
-70.37%8.00K
-62.50%9.00K
-67.57%12.00K
-91.07%5.00K
-82.91%27.00K
-65.22%24.00K
Operating profit
-21.90%-6.78M
-7.20%-6.28M
-11.86%-6.21M
-20.33%-6.39M
-43.95%-5.57M
-152.39%-5.86M
-55.87%-5.55M
-125.47%-5.31M
-104.98%-3.87M
-7.55%-2.32M
-99.78%-3.56M
-52.00%-2.36M
-18.54%-1.89M
-5.17%-2.16M
4.55%-1.78M
7.41%-1.55M
27.85%-1.59M
10.51%-2.05M
19.77%-1.87M
30.16%-1.67M
Net Profit
-38.52%-8.93M
-44.09%-6.93M
-21.75%-3.34M
-425.18%-4.58M
-223.90%-6.45M
49.00%-4.81M
20.72%-2.74M
126.11%1.41M
294.98%5.20M
-187.98%-9.44M
-27.86%-3.46M
-121.81%-5.40M
-1.95%-2.67M
-21.10%-3.28M
-25.25%-2.70M
-24.55%-2.44M
-5.82%-2.62M
-29.60%-2.71M
11.77%-2.16M
23.12%-1.96M
Current assets
213.23%25.03M
360.10%26.47M
7.12%6.08M
112.00%11.50M
-10.38%7.99M
-35.62%5.75M
652.79%5.68M
375.28%5.42M
560.52%8.92M
411.56%8.94M
-69.26%754.00K
-3.88%1.14M
-21.74%1.35M
-4.48%1.75M
9.80%2.45M
-19.53%1.19M
10.86%1.73M
-14.61%1.83M
-2.15%2.23M
-23.54%1.48M
Total current liabilities
5.64%3.76M
169.56%6.34M
50.59%3.56M
-34.96%8.79M
-71.81%3.56M
-83.27%2.35M
-59.99%2.37M
321.79%13.51M
-48.45%12.63M
-37.58%14.06M
-41.32%5.91M
-63.63%3.20M
169.73%24.50M
123.04%22.52M
12.39%10.08M
33.51%8.81M
72.36%9.09M
157.04%10.10M
67.39%8.97M
35.93%6.60M
Total assets
188.71%25.81M
305.57%27.30M
3.38%6.95M
66.95%12.41M
-16.50%8.94M
-38.00%6.73M
-43.80%6.72M
-39.11%7.43M
-12.78%10.71M
-13.37%10.86M
269.18%11.96M
508.07%12.21M
376.04%12.28M
361.38%12.53M
2.76%3.24M
-17.26%2.01M
1.50%2.58M
-14.05%2.72M
-19.64%3.15M
-42.26%2.43M
Total liabilities
-2.89%7.08M
86.99%9.67M
12.42%6.99M
-49.12%10.82M
-73.08%7.29M
-65.90%5.17M
-5.92%6.22M
445.62%21.26M
-21.61%27.10M
-53.39%15.16M
-67.86%6.61M
-77.29%3.90M
118.25%34.57M
127.41%32.54M
36.78%20.56M
38.31%17.16M
46.20%15.84M
54.45%14.31M
61.24%15.03M
56.06%12.40M
Total equity
1037.91%18.73M
1030.72%17.63M
-107.28%-37.00K
111.53%1.59M
110.04%1.65M
136.18%1.56M
-90.52%508.00K
-266.34%-13.83M
26.48%-16.39M
78.46%-4.31M
130.94%5.36M
154.87%8.31M
-68.12%-22.30M
-72.59%-20.00M
-45.81%-17.32M
-51.82%-15.15M
-59.90%-13.26M
-89.92%-11.59M
-120.07%-11.88M
-166.36%-9.98M
Net operating income
-78.24%-6.68M
-5.69%-4.57M
-31.47%-6.03M
-29.98%-3.85M
53.18%-3.75M
-174.06%-4.32M
-123.64%-4.59M
-58.91%-2.96M
-296.68%-8.01M
15.44%-1.58M
-55.34%-2.05M
-50.81%-1.86M
-15.64%-2.02M
-14.00%-1.86M
19.79%-1.32M
34.39%-1.24M
-3.07%-1.75M
37.79%-1.64M
-1.67%-1.65M
0.26%-1.88M
Net investment
39.13%-28.00K
---25.00K
100.00%0.00
-333.33%-13.00K
---46.00K
100.00%0.00
---5.00K
---3.00K
--0.00
99.86%-14.00K
--0.00
--0.00
--0.00
---10.00M
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--250.00K
100.00%0.00
Net financing
-6.61%5.20M
429.94%26.06M
-90.44%481.00K
7393.02%6.44M
3.78%5.57M
80.24%4.92M
151.55%5.03M
-95.70%86.00K
168.35%5.37M
-76.28%2.73M
33.33%2.00M
100.00%2.00M
0.00%2.00M
666.67%11.50M
20.00%1.50M
-50.00%1.00M
33.33%2.00M
-45.38%1.50M
26.01%1.25M
1.16%2.00M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its total revenue reached 130.00K, with a year-on-year change of 56.00K.

What are the current assets of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its current assets were 6.08M, with a year-on-year change of 7.12.

What are the total assets of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its total assets of Serina Therapeutics Inc were 6.95M, with a year-on-year change of 3.38.

What are the total liabilities of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its total liabilities of Serina Therapeutics Inc were 6.99M, with a year-on-year change of 12.42.

What is the total equity of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its total equity of Serina Therapeutics Inc was -37.00K, with a year-on-year change of -107.28.

What is the net operating income of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its net operating income of Serina Therapeutics Inc was -24.02M, with a year-on-year change of -40.91.

What is the net investment of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its net investment of Serina Therapeutics Inc was -59.00K, with a year-on-year change of -168.18.

What is the net financing of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its net financing of Serina Therapeutics Inc was 17.41M, with a year-on-year change of 31.79.

What is the Earnings Per Share (EPS) of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.88, with a year-on-year change of -24.34.

What is the net income of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its net income was -19.18M, with a year-on-year change of -72.17.

What is the net margin of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its net profit margin was -14780.77, with a year-on-year change of 26.14.

What is the Return on Assets (ROA) of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -281.02, with a year-on-year change of -134.32.

What is the operating profit of Serina Therapeutics Inc?

According to Serina Therapeutics Inc's FY2025 earnings report, its operating profit was -24.02M, with a year-on-year change of -40.91.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.